Objective: To assess the efficacy of 3-bromopyruvate (3-BrPA), a strong alkylating agent that inhibits hexokinase and mitochondrial oxidative phosphorylation, resulting in decreased cellular ATP production, on rabbit VX2 tumor cells. Methods: Adult New Zealand White rabbits were used for the study.
A new TRAIL to therapy of hepatocellular carcinoma: Blocking the proteasome
โ Scribed by Akira Anan; Gregory J. Gores
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 190 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND: The incidence of hepatocellular carcinoma (HCC) is increasing in the United States, and the care of these patients remains highly specialized and complex. Multiple treatment options are available for HCC but their use and effectiveness remain unknown. ## METHODS: Using
## Abstract Classifications of generalized carcinoma of the breast were based up to now on factors of definitely proven prognostic significance. These classifications are very useful in defining prognosis, but they help only to a limited extent in selecting treatment. We are proposing a new classif
sues with HCC. In noncancerous tissues of livers with Many studies concerning g-glutamyl transpeptidase HCC, the main types were types A and B. The prevalence (GGTP) in hepatocellular carcinoma (HCC) have sugof type B was significantly higher in both cancerous and gested that changes in hepatic GGTP